Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

Oncology, and Biosecurity Amid Strategic Program Developments ATLANTA, GA - April 16, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc.

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

“It is a single antigen vaccine. And for respiratory illnesses, the single antigen vaccines have never worked,” Kennedy said when asked by CBS’s chief medical correspondent, Jonathan ...

Wang et al. pursued a fresh approach by instead attaching antigens to a molecule that guides them to a key organelle — the endoplasmic reticulum (ER). This subcellular compartment is where ...

To date, the Food and Drug Administration (FDA) has approved seven chimeric antigen receptor-T (CAR-T) cell therapies and seven bispecific T-cell engagers (BiTEs) across a variety of hematologic ...

Boehringer Ingelheim has signed a strategic collaboration with UK biotech Enara Bio, focused on finding ways to fight cancer using “dark antigens” in a deal worth up to €876 million ($1.07bn).

Researchers are working on various approaches to make vaccination more practical: Vectored vaccines: Some vaccines use viral vectors, like adenoviruses, to deliver avian influenza antigens.

But what determines blood type and what does that blood type mean? Blood types are determined by antigens -- a substance that triggers an immune response -- on the surface of red blood cells.

Three newly identified RHAG antigens were linked to hemolytic disease of the fetus and newborn (HDFN). The RHAG system, short for Rh-associated glycoprotein, now includes six recognized antigens: two ...